The populations with the greatest disparities are adolescents, Black and Hispanic patients, and those with public or no ...

The second-line use of CDK4/6 inhibitors in advanced breast cancer saves substantial costs while maintaining health outcomes ...

ATH434 improves daily function and reduces brain iron in patients with multiple system atrophy, a rare, fatal ...

Shortages to backbone chemotherapy drugs are negatively affecting patient care, and more shortages are likely without policy ...

Prenatal lead exposure was associated with a significantly increased risk for major depressive disorder (MDD) in adulthood, ...

Nirsevimab continued to provide strong protection against respiratory syncytial virus-associated bronchiolitis in paediatric ...

Topline phase 3 results show that the novel nanobody gefurulimab is safe and effective for AChR-antibody-positive myasthenia gravis, but long-term results will be key.

Insurance-related and racial factors were the strongest predictors of planned oocyte cryopreservation (POC) in women in the ...

Current treatment options have been limited to symptom control. Telitacicept, a novel fusion protein, and ianalumab, a monoclonal antibody, demonstrate improvement in disease activity.

Cardiologists need to know how to recognize and manage the cardiac effects that can arise from SARS-CoV-2 infections or COVID ...

Difficulties with paying for household energy needs is linked to increased risk for both anxiety and depression in US adults, a new study suggests.

Continuous glucose monitoring can identify unrecognized hyperglycemia and hypoglycemia in dialysis patients, challenging reliance on A1c for diabetes management.